Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/222075
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Martín-carmona, Jésica | - |
dc.contributor.author | Corma-gómez, Anaïs | - |
dc.contributor.author | M. Moyano, Jose | - |
dc.contributor.author | Téllez, Francisco | - |
dc.contributor.author | Arenga-barrios, Dolores | - |
dc.contributor.author | Serrano-fuentes, Miriam | - |
dc.contributor.author | Carla Morano Vázquez, Aitana | - |
dc.contributor.author | Corona-mata, Diana | - |
dc.contributor.author | Nicolás Navarrete Lorite, Miguel | - |
dc.contributor.author | Jesús Vera-méndez, Francisco | - |
dc.contributor.author | Barroso, Isabel | - |
dc.contributor.author | Palacios, Rosario | - |
dc.contributor.author | De Los Santos, Ignacio | - |
dc.contributor.author | Belinchón, Olga | - |
dc.contributor.author | Galera, Carlos | - |
dc.contributor.author | Imaz, Arkaitz | - |
dc.contributor.author | Merino, Dolores | - |
dc.contributor.author | Javier Reus-bañuls, Sergio | - |
dc.contributor.author | Jose Galindo, Maria | - |
dc.contributor.author | Ángel López-zuñiga, Miguel | - |
dc.contributor.author | A. Pineda, Juan | - |
dc.contributor.author | Macías, Juan | - |
dc.date.accessioned | 2025-07-08T08:25:36Z | - |
dc.date.available | 2025-07-08T08:25:36Z | - |
dc.date.issued | 2025-05-01 | - |
dc.identifier.uri | https://hdl.handle.net/2445/222075 | - |
dc.description.abstract | Background After sustained virological response (SVR), liver stiffness (LS) usually decreases. However, information related to the impact of HIV co-infection in patients with advanced fibrosis is scarce. The aim was to analyze the impact of HIV co-infection on the LS dynamics after HCV cure. Methods Prospective study conducted in the GEHEP-011 multicenter cohort (initiated in October 2011-November 2023, ID NCT04460157), including patients with chronic HCV infection, with or without HIV co-infection, fulfilling: 1) SVR with direct-acting antivirals; 2) pre-treatment LS >= 9.5 kPa; 3) available measurement of LS at SVR. Pre-treatment, SVR and annual post-treatment LS were assessed. The primary outcome was time to LS normalization achievement (<= 7.2 kPa) in two consecutive examinations. Findings 1138 patients were included, 678 (60%) of whom were living with HIV (PLWH). The median time between the first to the last measure was 35 (17-69) months. In total, 390 [34% (95% confidence interval, 31%-37%)] patients achieved LS normalization, 169 [37% (CI 95%, 34%-43%)] individuals with HCV mono-infection vs. 221 [32% (CI 95%, 29%-36%)] PLWH achieved LS normalization (p = 0.003). The propensity score (PS) for HIV infection was calculated. In a multivariate model for competing risks (death was the competing event) adjusted for HIV, PS and diabetes, HIV infection was associated with a lower probability of achieving normalization [sHR = 0.82 (95% CI, 0.67-1.00), p = 0.045]. Matching by closer PS was performed. In the resultant subset, the probability of achieving LS normalization was again lower in PLWH [sHR = 0.76 (0.56-0.97), p < 0.001]. Interpretation After SVR, the probability of reaching LS normalization is significantly lower in PLWH. This could have implications on the development of long-term clinical events. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier BV | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1016/j.eclinm.2025.103227 | - |
dc.relation.ispartof | EClinicalMedicine, 2025, vol. 83, p. 103227 | - |
dc.relation.uri | https://doi.org/10.1016/j.eclinm.2025.103227 | - |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.title | Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response | - |
dc.type | info:eu-repo/semantics/article | - |
dc.date.updated | 2025-06-26T11:00:07Z | - |
dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S2589537025001592-main.pdf | 678.89 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.